Yoga adjunct was linked to lower ventricular premature contraction burden and better quality of life in small randomized trial

Current assessment: The available evidence supports a cautious report that a structured yoga program, used alongside standard medical care, was associated with lower ventricular premature contraction (VPC) burden and better patient-reported well-being in a randomized study from New Delhi. That is a meaningful finding, but it does not establish yoga as a stand-alone treatment for arrhythmias or show that it improves every cardiac outcome measured.

Reported facts

The peer-reviewed VPC-Yoga study was published online in JACC: Advances on September 17, 2026. Researchers recruited 134 people with frequent VPCs from the arrhythmia clinic at the All India Institute of Medical Sciences in New Delhi, India, and assigned 67 to structured yoga plus standard care and 67 to standard care alone.

The yoga group received instruction in a study-specific program that included stretching, postures, breathing practices and meditation. Participants were asked to practice for 45 minutes at least three times a week. The trial followed participants for 24 weeks.

The study’s primary outcome was change in VPC burden measured by 24-hour Holter monitoring. According to the published report, the adjusted between-group difference became statistically significant at 12 weeks. By 24 weeks, the yoga group also recorded better scores across the study’s quality-of-life measure and on depression, anxiety and stress assessments.

Supporting evidence

The strongest source is the original open-access journal article, which describes the research as a prospective, single-center randomized controlled trial. Outcome assessors were blinded to treatment allocation, and the researchers used an intention-to-treat analysis that included all 134 randomized participants. The trial was registered with India’s Clinical Trials Registry before its reported enrollment period.

The American College of Cardiology’s September 29 journal scan independently summarized the study and reported that the yoga group’s VPC burden fell more than the standard-care group’s at 12 weeks after adjustment for baseline values. It also reported no between-group differences in left-ventricular ejection fraction, heart-rate variability or major adverse cardiac and cerebrovascular events.

A cautious reading is that the findings appear consistent with yoga offering a useful supportive behavioral intervention for some patients with frequent VPCs who remain under clinical care. The study evaluated a defined, supervised-to-home-based program; it did not test yoga in place of usual treatment.

Limitations and competing evidence

The trial has important limits. It was conducted at one center, had 134 participants and was open-label, meaning participants knew whether they were assigned yoga. Those features can affect how broadly its findings apply and can influence self-reported outcomes such as quality of life and psychological symptoms.

Most importantly, the groups were not equivalent on the primary measure at baseline: median VPC burden was lower in the yoga group than in the control group. The authors adjusted their analysis for this imbalance, and the adjusted 12-week comparison was statistically significant. Still, the imbalance means the result deserves more caution than a trial beginning with closely matched arrhythmia burdens.

The available report also does not show that yoga improved left-ventricular ejection fraction, heart-rate variability or serious cardiovascular and cerebrovascular events during the 24-week follow-up. It therefore does not establish that yoga changes longer-term clinical risk, prevents complications or reduces the need for medication or catheter ablation.

Current conclusion

The available record supports reporting VPC-Yoga as an early randomized finding that structured yoga, added to standard care, was associated with a greater reduction in measured VPC burden at 12 weeks and improved patient-reported outcomes at 24 weeks in this New Delhi cohort. It does not establish yoga as a replacement for arrhythmia treatment or demonstrate improved major cardiac outcomes. Larger multicenter trials with longer follow-up, balanced baseline VPC burden and an activity-matched comparison group would materially clarify how much of the observed benefit is specific to the yoga intervention and whether it translates into durable clinical benefit.